Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018

Olivier J. Wouters(London School of Economics and Political Science), Jeroen Luyten(KU Leuven), Martin McKee(London School of Hygiene & Tropical Medicine)

JAMA

March 3, 2020

10.1001/jama.2020.1166

Cited by 1,480

Related Papers

Patient safety, satisfaction, and quality of hospital care: cross sectional surveys of nurses and patients in 12 countries in Europe and the United States

|BMJ|2012|2k

Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

|The Lancet|2019|2k

Consensus development methods, and their use in clinical guideline development.

|Health Technology Assessment|1998|1.9k

Systematic Literature Review on the Spread of Health-related Misinformation on Social Media

|Social Science & Medicine|2019|1.8k

Priority actions for the non-communicable disease crisis

|The Lancet|2011|1.6k